Passage BIO, Inc.
PASG- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001787297
No open-market purchases or sales by Passage BIO, Inc. insiders were filed in the last 90 days; 29 institutions reported holding it in 13F filings for Q2 2026, worth $6.82M in total; no superinvestor holds it.
13F holders, Q1 2025
Institutional positions in Passage BIO, Inc. as of Mar 31, 2025. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 42
- −4 vs. Q4 2024
- Shares held
- 36.3M
- −1.31M (−3.5%) vs. Q4 2024
- Total value
- $12.8M
- −$8.75M (−40.6%) vs. Q4 2024
- New holders
- 2
- 11 more added
- Sold out
- 6
- 11 more reduced
Compare with Q4 2024: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting PASG on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 29 | $6.82M |
| Q1 2026 | 35 | $13.8M |
| Q4 2025 | 30 | $18.6M |
| Q3 2025 | 32 | $13.2M |
| Q2 2025 | 41 | $13.0M |
| Q1 2025 | 42 | $12.8M |
| Q4 2024 | 46 | $21.6M |
| Q3 2024 | 45 | $27.1M |
| Q2 2024 | 45 | $32.0M |
| Q1 2024 | 51 | $54.4M |
| Q4 2023 | 52 | $33.1M |
| Q3 2023 | 51 | $21.3M |
| Q2 2023 | 56 | $31.4M |
| Q1 2023 | 59 | $34.0M |
| Q4 2022 | 68 | $51.6M |
| Q3 2022 | 76 | $49.3M |
| Q2 2022 | 87 | $99.6M |
| Q1 2022 | 110 | $133.2M |
| Q4 2021 | 102 | $277.7M |
| Q3 2021 | 103 | $419.1M |
| Q2 2021 | 102 | $558.8M |
| Q1 2021 | 90 | $786.5M |
Institutions, Q1 2025
Shares, value and share of portfolio for each institution holding Passage BIO, Inc.; share changes are against Q4 2024.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| CWM, LLC | 5 | $0 | 0.00% | 00.0% | Unchanged |
| TSFG, LLC | 100 | $0 | 0.00% | 00.0% | Unchanged |
| Group One Trading, L.P. | 47 | $17 | 0.00% | 00.0% | Unchanged |
| Farther Finance Advisors, LLC | 50 | $19 | 0.00% | 00.0% | Unchanged |
| Harbour Investments, Inc. | 60 | $21 | 0.00% | 00.0% | Unchanged |
| BNP Paribas Arbitrage, SA | 186 | $66 | 0.00% | 00.0% | Unchanged |
| LRI Investments, LLC | 225 | $79 | 0.00% | 00.0% | Unchanged |
| Bank of America Corp | 445 | $157 | 0.00% | +23+5.5% | Added |
| JPMorgan Chase & Co | 592 | $209 | 0.00% | +319+116.8% | Added |
| Advisor Group Holdings, Inc. | 2,000 | $706 | 0.00% | +230+13.0% | Added |
| MAI Capital Management | 4,000 | $1.41K | 0.00% | 00.0% | Unchanged |
| Barclays PLC | 4,224 | $1.49K | 0.00% | −8,929−67.9% | Reduced |
| SBI Securities Co., Ltd. | 5,278 | $1.86K | 0.00% | +2,909+122.8% | Added |
| Tower Research Capital LLC (TRC) | 6,316 | $2.23K | 0.00% | −48,163−88.4% | Reduced |
| Morgan Stanley | 6,829 | $2.41K | 0.00% | −805,613−99.2% | Reduced |
| Goldman Sachs Group Inc | 11,596 | $4.09K | 0.00% | −15,472−57.2% | Reduced |
| Mariner, LLC | 11,934 | $4.21K | 0.00% | +11,934 | New |
| UBS Group AG | 14,486 | $5.11K | 0.00% | +14,484+724,200.0% | Added |
| HighTower Advisors, LLC | 18,346 | $6.48K | 0.00% | +2,823+18.2% | Added |
| XTX Topco Ltd | 45,402 | $16.0K | 0.00% | +45,402 | New |
| Two Sigma Investments, LP | 46,955 | $16.6K | 0.00% | −2,409−4.9% | Reduced |
| DLK Investment Management, LLC | 53,000 | $18.7K | 0.01% | 00.0% | Unchanged |
| Squarepoint Ops LLC | 64,141 | $22.6K | 0.00% | +42+0.1% | Added |
| Simplex Trading, LLC | 82,346 | $29.0K | 0.00% | +81,771+14,221.0% | Added |
| Northern Trust Corp | 111,981 | $39.5K | 0.00% | +49,505+79.2% | Added |
| Millennium Management LLC | 136,224 | $48.1K | 0.00% | −12,383−8.3% | Reduced |
| RBF Capital, LLC | 142,807 | $50.4K | 0.00% | 00.0% | Unchanged |
| Shay Capital LLC | 146,717 | $51.8K | 0.02% | −78,544−34.9% | Reduced |
| State Street Corp | 156,773 | $55.4K | 0.00% | 00.0% | Unchanged |
| Fiduciary Trust Co | 215,000 | $75.9K | 0.00% | 00.0% | Unchanged |
| Bridgeway Capital Management, LLC | 506,142 | $178.7K | 0.00% | −50,000−9.0% | Reduced |
| Geode Capital Management, LLC | 546,101 | $192.9K | 0.00% | +14,536+2.7% | Added |
| BlackRock, Inc. | 718,450 | $253.7K | 0.00% | −3,846−0.5% | Reduced |
| Acadian Asset Management LLC | 933,764 | $328.0K | 0.00% | −9,136−1.0% | Reduced |
| Renaissance Technologies LLC | 1,410,276 | $498.0K | 0.00% | +28,800+2.1% | Added |
| Tang Capital Management LLC | 1,500,000 | $529.6K | 0.03% | 00.0% | Unchanged |
| Vanguard Group Inc | 2,071,538 | $731.3K | 0.00% | 00.0% | Unchanged |
| Erste Asset Management GmbH | 2,455,800 | $868.7K | 0.01% | 00.0% | Unchanged |
| New Leaf Venture Partners, L.L.C. | 2,497,922 | $881.8K | 1.96% | 00.0% | Unchanged |
| Vestal Point Capital, LP | 6,100,000 | $2.15M | 0.15% | 00.0% | Unchanged |
| OrbiMed Advisors LLC | 7,034,626 | $2.48M | 0.06% | −370,243−5.0% | Reduced |
| Lynx1 Capital Management LP | 9,256,953 | $3.27M | 1.17% | 00.0% | Unchanged |
| Jane Street Group, LLC | 0 | $0 | 0.00% | −78,190−100.0% | Sold out |
| Ground Swell Capital, LLC | 0 | $0 | 0.00% | −25,424−100.0% | Sold out |
| FMR LLC | 0 | $0 | 0.00% | −21,054−100.0% | Sold out |
| HRT Financial LP | 0 | $0 | 0.00% | −13,850−100.0% | Sold out |
| Virtu Financial LLC | 0 | $0 | 0.00% | −10,286−100.0% | Sold out |
| Atria Wealth Solutions, Inc. | 0 | $0 | 0.00% | −10,000−100.0% | Sold out |